Connecting you to content on EBSCOhost

Works by Brok, Ingrid

Results: 3

1

Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model.

Published in:

OncoImmunology, 2020, v. 9, n. 1, p. 1, doi. 10.1080/2162402X.2020.1817653

By:

van den Bijgaart, Renske J. E.;
Kroesen, Michiel;
Brok, Ingrid C.;
Reijnen, Daphne;
Wassink, Melissa;
Boon, Louis;
Hoogerbrugge, Peter M.;
Adema, Gosse J

Publication type:

Article

2

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma.

Published in:

OncoImmunology, 2016, v. 5, n. 6, p. 1, doi. 10.1080/2162402X.2016.1164919

By:

Kroesen, Michiel;
Büll, Christian;
Gielen, Paul R.;
Brok, Ingrid C.;
Armandari, Inna;
Wassink, Melissa;
Looman, Maaike W. G.;
Boon, Louis;
den Brok, Martijn H.;
Hoogerbrugge, Peter M.;
Adema, Gosse J.

Publication type:

Article

3

Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents.

Published in:

Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 563, doi. 10.1007/s00262-015-1663-y

By:

Kroesen, Michiel;
Brok, Ingrid;
Reijnen, Daphne;
Hout-Kuijer, Maaike;
Zeelenberg, Ingrid;
Brok, Martijn;
Hoogerbrugge, Peter;
Adema, Gosse

Publication type:

Article